Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer
N
Shared by NobleBlocks on Jul 1, 2018 • 12:00 AM UTC
Authors:
G.N. Hortobagyi
,
S.M. Stemmer
,
H.A. Burris
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer | NobleBlocks
